Integra LifeSciences (IART) News Today → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free IART Stock Alerts $30.90 +0.10 (+0.32%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 4:52 AM | marketbeat.com672,141 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Acquired by Norges BankNorges Bank bought a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 672,141 shares of the life sciences company's stock, valued at approximatMay 28, 2024 | markets.businessinsider.comNotice to Shareholders of Integra LifeSciences Holdings Corporation (IART): Grabar Law Office Is Investigating Claims on Your BehalfMay 26, 2024 | marketbeat.comDimensional Fund Advisors LP Raises Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Dimensional Fund Advisors LP increased its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,615,112 shares of the life sciences company's stock after acquiring an aMay 26, 2024 | insidertrades.comStuart Essig Acquires 52,641 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) StockMay 24, 2024 | marketbeat.comInsider Buying: Integra LifeSciences Holdings Co. (NASDAQ:IART) Chairman Purchases 52,641 Shares of StockIntegra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) Chairman Stuart Essig bought 52,641 shares of Integra LifeSciences stock in a transaction dated Thursday, May 23rd. The stock was acquired at an average cost of $28.49 per share, for a total transaction of $1,499,742.09. Following the purchase, the chairman now directly owns 487,922 shares in the company, valued at approximately $13,900,897.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.May 24, 2024 | marketbeat.comVictory Capital Management Inc. Has $608,000 Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Victory Capital Management Inc. cut its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 99.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,971 shares of theMay 24, 2024 | americanbankingnews.comIntegra LifeSciences (NASDAQ:IART) Trading Up 4% After Analyst UpgradeMay 23, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Trading 4% Higher Following Analyst UpgradeIntegra LifeSciences (NASDAQ:IART) Trading 4% Higher on Analyst UpgradeMay 23, 2024 | americanbankingnews.comIntegra LifeSciences (NASDAQ:IART) Price Target Raised to $28.00 at CitigroupMay 22, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) PT Raised to $28.00Citigroup upped their price target on Integra LifeSciences from $24.00 to $28.00 and gave the stock a "neutral" rating in a research note on Wednesday.May 22, 2024 | marketbeat.comClearbridge Investments LLC Sells 267,673 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Clearbridge Investments LLC lessened its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 9.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,474,249 shares of the life sciences company's stock afMay 21, 2024 | marketbeat.comGW&K Investment Management LLC Trims Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART)GW&K Investment Management LLC trimmed its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 8.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 693,553May 17, 2024 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Short Interest UpdateIntegra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totalling 2,450,000 shares, a decline of 6.1% from the April 15th total of 2,610,000 shares. Based on an average daily volume of 985,300 shares, the short-interest ratio is presently 2.5 days. Approximately 3.7% of the company's stock are short sold.May 13, 2024 | globenewswire.comIntegra LifeSciences to Present at the 2024 Bank of America Healthcare ConferenceMay 7, 2024 | markets.businessinsider.comIntegra Lifesciences Sell Rating Justified Amid Operational Delays and Market SkepticismMay 7, 2024 | markets.businessinsider.comIntegra Lifesciences: Overcoming Temporary Setbacks with Strong Growth ProspectsMay 7, 2024 | benzinga.comA Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 AnalystsMay 7, 2024 | msn.comIntegra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2024 Earnings Call TranscriptMay 7, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Sees Strong Trading VolumeIntegra LifeSciences (NASDAQ:IART) Sees Unusually-High Trading VolumeMay 7, 2024 | marketbeat.comMorgan Stanley Trims Integra LifeSciences (NASDAQ:IART) Target Price to $24.00Morgan Stanley cut their price objective on Integra LifeSciences from $37.00 to $24.00 and set an "underweight" rating for the company in a research note on Tuesday.May 7, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Issues Quarterly Earnings ResultsIntegra LifeSciences (NASDAQ:IART - Get Free Report) announced its quarterly earnings results on Monday. The life sciences company reported $0.55 EPS for the quarter, meeting the consensus estimate of $0.55. Integra LifeSciences had a return on equity of 15.19% and a net margin of 4.39%. The firm had revenue of $368.90 million for the quarter, compared to analyst estimates of $361.96 million. During the same quarter last year, the firm posted $0.74 earnings per share. The business's revenue for the quarter was down 3.2% on a year-over-year basis.May 7, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Rating Lowered to Market Perform at OppenheimerOppenheimer cut shares of Integra LifeSciences from an "outperform" rating to a "market perform" rating in a report on Tuesday.May 7, 2024 | finance.yahoo.comIntegra Lifesciences Holdings Corp (IART) Q1 2024 Earnings Call Transcript Highlights:May 7, 2024 | finance.yahoo.comQ1 2024 Integra Lifesciences Holdings Corp Earnings CallMay 7, 2024 | finance.yahoo.comIntegra Lifesciences Holdings Corp (IART) Q1 2024 Earnings Call Transcript Highlights: ...May 6, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Reaches New 1-Year Low at $24.16Integra LifeSciences (NASDAQ:IART) Reaches New 52-Week Low at $24.16May 6, 2024 | marketwatch.comIntegra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit FindingsMay 6, 2024 | seekingalpha.comIntegra LifeSciences Holdings Corporation 2024 Q1 - Results - Earnings Call PresentationMay 6, 2024 | marketbeat.comTrading was temporarily halted for "IART" at 09:05 AM with a stated reason of "LULD pause."May 6, 2024 | finanznachrichten.deIntegra LifeSciences Holdings Corporation: Integra LifeSciences Reports First Quarter 2024 Financial ResultsMay 6, 2024 | washingtonpost.comIntegra: Q1 Earnings SnapshotMay 6, 2024 | markets.businessinsider.comIntegra LifeSciences Turns To Net Loss In Q1; Adj. Profit In Line; Revises Annual GuidanceMay 6, 2024 | finance.yahoo.comIntegra LifeSciences Q1 Adjusted Earnings, Revenue Fall; Updates 2024 OutlookMay 6, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Releases FY24 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its FY24 earnings guidance. The company provided EPS guidance of $3.01-3.11 for the period, compared to the consensus estimate of $3.19. The company also issued revenue guidance of $1.67-1.69 billionillion, compared to the consensus estimate of $1.62 billionillion.May 6, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Releases Q2 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its second quarter earnings guidance. The company provided EPS guidance of $0.60-0.65 for the period, compared to the consensus estimate of $0.74. The company also issued revenue guidance of $411-416 millionillion, compared to the consensus estimate of $395.81 millionillion.May 6, 2024 | marketbeat.comFisher Asset Management LLC Trims Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART)Fisher Asset Management LLC lowered its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 15.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 396,798 shares of the life sciences comMay 6, 2024 | globenewswire.comIntegra LifeSciences Reports First Quarter 2024 Financial ResultsMay 3, 2024 | msn.comIntegra LifeSciences Holdings Q1 2024 Earnings PreviewApril 30, 2024 | marketbeat.comStockNews.com Lowers Integra LifeSciences (NASDAQ:IART) to HoldStockNews.com cut Integra LifeSciences from a "buy" rating to a "hold" rating in a report on Tuesday.April 30, 2024 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Short Interest Up 24.9% in AprilIntegra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 2,610,000 shares, an increase of 24.9% from the March 31st total of 2,090,000 shares. Approximately 4.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 725,500 shares, the short-interest ratio is presently 3.6 days.April 30, 2024 | globenewswire.comIntegra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific MeetingApril 26, 2024 | markets.businessinsider.comBuy Rating for Integra Lifesciences Amid Favorable Medicare Policy ChangesApril 25, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Reaches New 52-Week Low at $27.18Integra LifeSciences (NASDAQ:IART) Hits New 12-Month Low at $27.18April 24, 2024 | nasdaq.comFirst Week of December 20th Options Trading For Integra LifeSciences Holdings (IART)April 22, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Sells 26,513 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Allspring Global Investments Holdings LLC lowered its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 37.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44April 21, 2024 | marketbeat.comCooke & Bieler LP Has $123.45 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Cooke & Bieler LP raised its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 4.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 2,834,604 shares of the life sciences company's stock after purchasing an additional 120,April 19, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Shares Down 4.7% Integra LifeSciences (NASDAQ:IART) Shares Down 4.7%April 18, 2024 | globenewswire.comIntegra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024April 18, 2024 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Reaches New 1-Year Low at $31.53Integra LifeSciences (NASDAQ:IART) Reaches New 1-Year Low at $31.53April 17, 2024 | nasdaq.comIntegra LifeSciences Holdings Enters Oversold Territory (IART) Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now IART Media Mentions By Week IART Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IART News Sentiment▼1.190.76▲Average Medical News Sentiment IART News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IART Articles This Week▼34▲IART Articles Average Week Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MDXG News GMED News MASI News ITGR News ATEC News ATRC News OFIX News SRDX News ANGO News ARAY News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IART) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
